Creating the Largest Real-World Evidence Platform for Patients and Fuels Innovation: Holmusk

Providing a solution for Mental Health - the "Cancer" of tomorrow

Mental health disorders remain the highest unmet medical need, surpassing cardiovascular disease, diabetes, and cancer. Cumulative economic burden exceeds 16 Trillion USD in direct and indirect costs. Holmusk addresses this problem by building the world's largest Real-World Evidence (RWE) platform for mental health to deliver clinical and regulatory grade evidence to all major stakeholders of the healthcare ecosystem.

The company’s proprietary technology is also harnessed to analyze real-world data across other chronic metabolic diseases including diabetes, cardiovascular disease, chronic kidney disease, etc. By integrating the work on metabolic diseases with the mental health RWE platform it can generate even deeper insights. The company’s goal is to develop a system-wide integrated care model between mental and chronic health which makes access to RWE a reality of today, rather than a dream of tomorrow.

Data Analytics

Holmusk analytics work in the intersection of pharma& healthcare practice. It's model help identify patients with unmet needs; those who will benefit most from new interventions, and provide biological insights to facilitate new drug research & development.

The company’s Analytics Platform leverages scientific research, digital health, and EHR data to inform predictive algorithms and provide actionable insights for personalized medicine.

Statistical analysis of clinical trial data has been standardized over the years. With the entry of real-world data (RWD) from EHRs and data captured through digital platforms, there is a need for a new approach. The challenge of generating validated evidence from RWD is particularly acute in behavioral health and chronic diseases due to multimorbidity and polypharmacy.

Specialty Electronic Health Records

Holmusk aims are to advance data-driven decision-making in mental health practice and research. Its specialty EHR system is designed to better capture and monitor decisions and is combined with past mental health records to continuously improve the longitudinal data necessary for advanced analytics. Holmusk’sMindLinc is an Electronic Health Record (EHR) system built exclusively for mental health disorders. Believing in the ability of data science to uncover insights that lead to better outcomes in mental health, Holmusk acquired MindLinc from Duke University in 2016, with the goal of making it a global leader and unlocking the convergence of innovative technology and healthcare.

Designed by leading researchers and scientists from Duke University Medical Center, the EHR platform was designed to allow more contact time with patients by reducing administrative burden, and enable research and clinical decision support.

For the past 20 years, MindLinc has served as the new age EHR for behavioral sciences, making it one of the world’s largest behavioral health clinical databases, not only in the amount of data collected but also in the scope of mental health issues covered. Specifically designed to advance data-driven decision-making in mental health practice and research, Holmusk is creating the largest and most comprehensive structured mental health database, and working to provide regulatory-grade and clinical research-grade real-world evidence datasets.

Digital Therapeutics

The firm empowers patients with mental health conditions and chronic diseases to stay healthy at home and in the community. Every day, its digital tools are used by thousands of people to manage their conditions in an effective and engaging way. Technology will radically change how healthcare is delivered: enabling a better quality of care & patient experience on a massive scale. The firm is building a new, digital future.

Holmusk draws upon the latest in consumer technology to deliver a complete patient experience through your mobile phone: simple to use, highly personalized and accessible whenever you need it.

The Leader and Founder

Nawal Roy | Founder &CEO

Nawal Roy is the founder and CEO of Holmusk, bringing more than fifteen years of finance and strategy consulting experience to the helm of the company. Before this, Nawal was Co-Founder and CEO of HelloPay (Rocket Internet venture), and a Junior Partner at McKinsey & Company. He has served as a Steering Committee member (Value-Based Health Care) for the World Economic Forum and co-founded Galen Growth Asia - The Asia HealthTech Connector. Having enjoyed a global career spanning from New York to Tokyo, his close involvement with markets across North America, Europe, Southeast Asia, India, and China yields uniquely diverse experience in building next-generation global companies.

Nawal carves out the strategic direction of Holmusk, leading from the front with round-the-clock hustle and infectious energy. Driving business development, partnerships, and growth, his mission is to build a company founded on the commitment to solving some of the world’s greatest challenges in healthcare.

“We aim to transform the lives of people with behavioral health and chronic diseases through data-driven medicine.”